Humoral response of cynomolgus macaques to human soluble CD4: antibody reactivity restricted to xeno-human determinants.
The CD4 cell surface glycoprotein which is expressed primarily by a subset of T lymphocytes plays a key role in normal immune responses. In the immunopathogenesis of AIDS, it serves as the high-affinity receptor for HIV, facilitating viral attachment and entry into CD4+ cells. As such, the truncated soluble form of this molecule (sT4) has been proposed as a therapeutic drug for the treatment of AIDS whereby it would act as decoy for viral entry into cells or facilitate elimination of soluble viral envelope glycoprotein. In a study designed to look at the effect of sT4 on immune function, sT4 was administrated to experimentally naive primates. In this report, we show that administration of sT4 to cynomolgus macaque monkeys over a period of up to 3 weeks results in antibody responses with specificities for human CD4 molecules. Antisera thus generated bound sT4 and cell surface CD4 expressed on human T lymphocytes but failed to bind to cynomolgus lymphocytes. These antibodies caused no apparent adverse effects on normal immune functions of the cynomolgus macaques. We conclude from these data that the antibody response to soluble CD4 in cynomolgus monkeys is directed at determinants present on human CD4 but absent on monkey CD4. The restricted xenogeneic specificity of the antibody response indicates that soluble CD4 may not be highly immunogenic in syngeneic hosts. The present study also shows that these antibodies can block HIV-induced syncytium formation indicating that the antibodies bind to regions on the CD4 molecule close to the HIV-env gp120 binding site. The gp120 binding site, which resides within the N-terminal V1 domain of CD4, encompasses a region which corresponds to the complementarity determining regions (CDRs) of immunoglobulins. The CDR-like regions of CD4-V1 manifest the greatest species divergence, are tolerant to experimental in vitro mutagenesis, and generate the predominant antibody response in mice immunized with human CD4 indicating that differences in the V1 sequence between human and other non-human primates may localize to this regions.
Truneh
A
A
Department of Immunology, Smith Kline & French Laboratories, Philadelphia, Pennsylvania.
Frescatore
R L
RL
Thiem
P
P
Leary
J J
JJ
Rosenberg
M
M
Hanna
N
N
Sweet
R
R
Bugelski
P J
PJ
D000818:Animals; D000910:Antibodies, Heterophile / Q000096:biosynthesis*; D015478:Antigens, Heterophile / Q000276:immunology*; D015704:CD4 Antigens / Q000276:immunology*; D000939:Epitopes / Q000276:immunology; D005260:Female; D015726:Giant Cells / Q000276:immunology; D006678:HIV / Q000502:physiology; D006801:Humans; D016131:Lymphocyte Subsets / Q000737:chemistry / Q000382:microbiology; D008252:Macaca fascicularis; D008297:Male; D013329:Structure-Activity Relationship
D000910:Antibodies, Heterophile; D015478:Antigens, Heterophile; D015704:CD4 Antigens; D000939:Epitopes